CFIUS/UK Authorities Review Chinese Purchase of Pharmaceutical Company

Simon Lester -

An acquisition of a U.S./UK pharmaceutical company by a company with China ties is being reviewed by the Committee on Foreign Investment in the United States (CFIUS) and its UK counterpart.